These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38627584)

  • 21. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
    Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
    BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis.
    Datta N; Islam S; Chatterjee U; Chatterjee S; Panda CK; Ghosh MK
    Cell Death Dis; 2019 Sep; 10(9):656. PubMed ID: 31506431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Krüppel-like Factor 4-p21
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Stem Cell Phenotypes in ER
    Truong TH; Hu H; Temiz NA; Hagen KM; Girard BJ; Brady NJ; Schwertfeger KL; Lange CA; Ostrander JH
    Mol Cancer Res; 2018 Apr; 16(4):707-719. PubMed ID: 29348189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
    Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
    Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.
    Bergamaschi A; Madak-Erdogan Z; Kim YJ; Choi YL; Lu H; Katzenellenbogen BS
    Breast Cancer Res; 2014 Sep; 16(5):436. PubMed ID: 25213081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.
    Wen S; Qin Y; Wang R; Yang L; Zeng H; Zhu P; Li Q; Qiu Y; Chen S; Liu Y; Hou Y; Tang X; Liu M; Tu G
    Cell Death Dis; 2021 May; 12(5):437. PubMed ID: 33934099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 29. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.
    Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J
    Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
    Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
    Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16
    Shimoda H; Doi S; Nakashima A; Sasaki K; Doi T; Masaki T
    Kidney Int; 2019 Nov; 96(5):1162-1175. PubMed ID: 31570196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese encephalitis virus perturbs PML-nuclear bodies by engaging in interactions with distinct porcine PML isoforms.
    Yang S; Liu H; Chen Z; Wang H; Li X; Zhou X; Zhao A
    Front Cell Infect Microbiol; 2023; 13():1239234. PubMed ID: 37928180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
    Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
    Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.
    Deng H; Zhang XT; Wang ML; Zheng HY; Liu LJ; Wang ZY
    PLoS One; 2014; 9(2):e88034. PubMed ID: 24558373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen-induced circRNA, circPGR, functions as a ceRNA to promote estrogen receptor-positive breast cancer cell growth by regulating cell cycle-related genes.
    Wang L; Yi J; Lu LY; Zhang YY; Wang L; Hu GS; Liu YC; Ding JC; Shen HF; Zhao FQ; Huang HH; Liu W
    Theranostics; 2021; 11(4):1732-1752. PubMed ID: 33408778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation.
    Xu M; Liu X; Zhou X; Qin Y; Yang L; Wen S; Qiu Y; Chen S; Tang R; Guo Y; Liu M; Sun Y
    Pharmacol Res; 2023 Nov; 197():106964. PubMed ID: 37865128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
    Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.